Combined R2* and diffusion tensor imaging changes in the substantia nigra in Parkinson's disease.
about
Multimodal MRI Evaluation of the MitoPark Mouse Model of Parkinson's DiseaseDelayed hippocampal effects from a single exposure of prepubertal guinea pigs to sub-lethal dose of chlorpyrifos: a magnetic resonance imaging and spectroscopy studyExamining the relationship between head trauma and neurodegenerative disease: A review of epidemiology, pathology and neuroimaging techniquesThe perplexing paradox of paraquat: the case for host-based susceptibility and postulated neurodegenerative effectsMicrostructural changes in the substantia nigra of asymptomatic agricultural workersIs R2* a new MRI biomarker for the progression of Parkinson's disease? A longitudinal follow-up.The evolving role of diffusion magnetic resonance imaging in movement disordersMRI reveals brain abnormalities in drug-naive Parkinson's disease.A review of the use of magnetic resonance imaging in Parkinson's disease.Increased free water in the substantia nigra of Parkinson's disease: a single-site and multi-site study.Longitudinal changes in free-water within the substantia nigra of Parkinson's diseaseUsefulness of R2* maps generated by iterative decomposition of water and fat with echo asymmetry and least-squares estimation quantitation sequence for cerebral artery dissection.Free-water imaging in Parkinson's disease and atypical parkinsonism.R2* Map by IDEAL IQ for Acute Cerebral Infarction: Compared with Susceptibility Vessel Sign on T2*-Weighted Imaging.Advanced magnetic resonance imaging of neurodegenerative diseases.The clinical utility of QSM: disease diagnosis, medical management, and surgical planning.Targeting chelatable iron as a therapeutic modality in Parkinson's disease.Serum cholesterol and nigrostriatal R2* values in Parkinson's disease.Does structural neuroimaging reveal a disturbance of iron metabolism in Parkinson's disease? Implications from MRI and TCS studies.Diffusion tensor imaging in parkinsonian syndromes: a systematic review and meta-analysis.A multicontrast approach for comprehensive imaging of substantia nigra.Potential of Diffusion Tensor Imaging and Relaxometry for the Detection of Specific Pathological Alterations in Parkinson's Disease (PD)Magnetic Resonance Imaging Features of the Nigrostriatal System: Biomarkers of Parkinson's Disease Stages?Parkinson's disease biomarkers program brain imaging repository.The role of high-field magnetic resonance imaging in parkinsonian disorders: Pushing the boundaries forward.Region-Specific Iron Measured by MRI as a Biomarker for Parkinson's Disease.Diffusion Kurtosis Imaging of Substantia Nigra Is a Sensitive Method for Early Diagnosis and Disease Evaluation in Parkinson's Disease.Imaging nigral pathology and clinical progression in Parkinson's disease.Higher iron in the red nucleus marks Parkinson's dyskinesia.Multimodal Imaging Signatures of Parkinson's Disease.Increased R2* in the Caudate Nucleus of Asymptomatic Welders.Thalamic projection fiber integrity in de novo Parkinson disease.Lateral Asymmetry and Spatial Difference of Iron Deposition in the Substantia Nigra of Patients with Parkinson Disease Measured with Quantitative Susceptibility MappingDiffusion tensor imaging of Parkinson's disease, atypical parkinsonism, and essential tremorA multimodal imaging analysis of subcortical gray matter in fragile X premutation carriers.Diffusion tensor imaging of nigral degeneration in Parkinson's disease: A region-of-interest and voxel-based study at 3 T and systematic review with meta-analysis.Multi-atlas segmentation of subcortical brain structures via the AutoSeg software pipeline.Axonal damage and loss of connectivity in nigrostriatal and mesolimbic dopamine pathways in early Parkinson's disease.Brain iron accumulation in aging and neurodegenerative disorders.Magnetic Resonance Imaging (MRI) in Parkinson's Disease.
P2860
Q27316725-CF3A8FCA-8904-474E-974F-D8883604929BQ28383723-385793D4-8BA4-4FFB-82B6-C24FE4080846Q28395854-0AC1E7E4-07D2-41AD-A26C-B3E11B1166E6Q28396222-E1A326DB-48AF-49B1-ABC3-C90A4BE55E8AQ28397004-28546DE6-DD37-4C2C-8DE7-99EB84B3F63CQ30457611-923A93A9-5E2B-47E6-845F-6C844F6D3982Q30667544-6500355D-E580-4A8F-8887-E017A16B4C3EQ30688718-D9B8AC02-A97C-4C99-A6A9-C4504B9A82BFQ30835548-E931859C-BB52-43AB-A4C8-74C69F20AAA1Q30873974-69C80D75-240B-495D-B86A-0BEB0313CCC6Q30952963-AD2BD85C-8500-42E3-A925-8DC7477ED258Q30970801-AFC5FF79-21C2-447B-813C-69ECA664DCDDQ31034031-98F3DF4A-DF24-45F4-A359-CA1B90B1D80CQ31135111-5124B144-877C-46CA-B0D1-D712EE6EE3C1Q31142517-9597A304-6873-44F6-95AD-90E4E098E592Q31146333-31DB691F-18D4-4725-8776-B355E816201DQ33768106-9100C7CB-58BC-4200-806F-F65AE040ED51Q34243731-8A0D0260-5FAB-45AA-9A1B-93493782A7C9Q34372099-80C9A3C6-DBF3-4EEE-A0AB-12F87E7A2E78Q34601225-83CE2DCE-F434-4BBD-82F8-E7D09B839053Q35555926-781DC0DC-CA14-411E-A309-0424A15C08B1Q35880556-73A2B44C-339E-4491-809F-C5DF0E071B6DQ35976522-C50CA498-8AB9-4EC2-A01D-84D166CC2759Q36276040-8668087E-A955-462E-B312-AF5CEFA1F923Q36332532-4D06299A-A468-42D0-BDDF-D3924D61FBDCQ36374541-AF194EDE-80D2-4435-A7E2-15FBC9C0D79DQ36378779-26001365-884A-4F4E-8334-CDF384350CFBQ36434577-973082B2-D403-4DE6-B273-0A174FBEF8CAQ36605028-9CB1E96E-B3AB-4E71-BB86-536443BAB7D3Q36805798-9622908C-C905-41C3-B844-CA38B70909C5Q36871031-D5001002-4B48-460E-8C7A-9934853BF25CQ36893101-E1BC04A1-42DB-4CC9-AE03-1DD38B7E20CDQ36902028-CDB88244-79C8-4950-951C-5C6A3F7B82DDQ37106984-270DF551-522B-4FFA-9AAB-6DF49B06E093Q37204665-D1ADAA18-6647-4471-BB6C-FC7A555AC61EQ37313955-60478268-1221-48EC-A3A0-DF89972127FDQ37558908-1BF318E8-6749-4788-B95B-3E1684A13AB3Q37737032-4E2A20FB-352C-4C26-BB4C-D9FC8946C8DEQ38067144-6CAF29D7-CFD9-419B-8E85-8A3B6470DD3EQ38281082-1407DA3E-537A-47AB-8235-3AE1D18702E9
P2860
Combined R2* and diffusion tensor imaging changes in the substantia nigra in Parkinson's disease.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Combined R2* and diffusion ten ...... nigra in Parkinson's disease.
@ast
Combined R2* and diffusion ten ...... nigra in Parkinson's disease.
@en
type
label
Combined R2* and diffusion ten ...... nigra in Parkinson's disease.
@ast
Combined R2* and diffusion ten ...... nigra in Parkinson's disease.
@en
prefLabel
Combined R2* and diffusion ten ...... nigra in Parkinson's disease.
@ast
Combined R2* and diffusion ten ...... nigra in Parkinson's disease.
@en
P2093
P2860
P356
P1433
P1476
Combined R2* and diffusion ten ...... nigra in Parkinson's disease.
@en
P2093
Guangwei Du
Mechelle M Lewis
Michele L Shaffer
Qing X Yang
P2860
P304
P356
10.1002/MDS.23643
P407
P577
2011-05-26T00:00:00Z